TLR Signaling Is Activated in Lymph Node-Resident CLL Cells and Is Only Partially Inhibited by Ibrutinib.

Saved in:
Bibliographic Details
Title: TLR Signaling Is Activated in Lymph Node-Resident CLL Cells and Is Only Partially Inhibited by Ibrutinib.
Authors: Dadashian EL; Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland., McAuley EM; Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland., Liu D; Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland., Shaffer AL 3rd; Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Young RM; Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Iyer JR; Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland., Kruhlak MJ; Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Staudt LM; Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Wiestner A; Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland., Herman SEM; Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland. Sarah.Herman@nih.gov.
Source: Cancer research [Cancer Res] 2019 Jan 15; Vol. 79 (2), pp. 360-371. Date of Electronic Publication: 2018 Nov 29.
Publication Type: Journal Article; Research Support, N.I.H., Intramural
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1538-7445
DOI:10.1158/0008-5472.CAN-18-0781